- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04165733
Professional Quality of Life in German Psychiatrists
February 13, 2025 updated by: Moritz Petzold, Charite University, Berlin, Germany
Professional Quality of Life in German Psychiatrists Working with Patients with Mental Disorders
The purpose of this study is to assess professional quality of life in German psychiatrists working with patients with mental disorders.
Study Overview
Status
Suspended
Intervention / Treatment
Detailed Description
The purpose of this study is to assess professional quality of life, which includes compassion satisfaction, burnout and secondary traumatization in psychiatrists, working with patients with mental disorders, in Germany.
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany, 10117
- Charité Universitätsmedizin Berlin - Department for Psychiatry and Psychotherpy - Charité Campus Mitte
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Psychiatrists (already specialzied in psychiatry or currently in specialization for psychiatry) that currently work with patients with mental disorders in Germany.
Description
Inclusion Criteria:
- Psychiatrits (Physician with specialization in psychiatry or currently in specialization for psychiatry)
- Currently working with patients with mental disorders
- At least 18 years old
- Sufficient German skills for answering the questionnaire
Exclusion Criteria:
None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Psychiatrists in Germany
Psychiatrists in Germany currently working with patients with mental disorders
|
Clinical psychologists in Germany currently working with patients with mental disorders
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compassion Satisfaction
Time Frame: 1 day
|
Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL) - German Version - Subscale "Compassion Satisfaction" (Minimum: 10 - Maximum: 50 - Higher scores mean a higher compassion satisfaction.
|
1 day
|
|
Burnout
Time Frame: 1 day
|
Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL) - German Version - Subscale "Burnout" (Minimum: 10 - Maximum: 50 - Higher scores mean a higher level of burnout.
|
1 day
|
|
Traumatization
Time Frame: 1 day
|
Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL) - German Version - Subscale "Secondary Traumatization" (Minimum: 10 - Maximum: 50 - Higher scores mean a higher level of secondary traumatization.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Moritz B Petzold, Dipl.-Psych., Charité Universitätsmedizin Berlin- Charité Campus Mitte - Department for Psychiatry and Psychotherapy
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 16, 2020
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
November 14, 2019
First Submitted That Met QC Criteria
November 14, 2019
First Posted (Actual)
November 18, 2019
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 13, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ProQol_A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.